Chapet Olivier, Kong Feng-Ming, Lee Julia S, Hayman James A, Ten Haken Randall K
Department of Radiation Oncology, University of Michigan, Ann Arbor, USA.
Radiother Oncol. 2005 Nov;77(2):176-81. doi: 10.1016/j.radonc.2005.10.001. Epub 2005 Oct 26.
To evaluate the ability of a well-known normal tissue complication probability (NTCP) model to predict radiation esophagitis by determining updated model parameters and then comparing these results with the predictive value of other dosimetric parameters.
Clinical and dosimetric data regarding esophagitis were analyzed in 101 inoperable/unresectable non-small-cell lung cancer patients treated by external beam irradiation. Grade 2 or higher esophagitis counted as events. Parameters (TD50, n, and m) of the Lyman normal tissue complication probability (NTCP) model were determined using maximum likelihood analysis, and compared to other dose/volume threshold values including: percentage of esophagus receiving > 40 Gy (V40) to > 75 Gy (V75), and maximum esophageal doses.
Sixteen patients developed grade 2-3 acute esophagitis (no G4 or 5). The maximum likelihood analysis produced new Lyman model parameters of: TD50 = 51 Gy, n = 0.44 and m = 0.32. The mean NTCP value is significantly lower (P < 0.001) in the group of patients without esophagitis (13.5%) than with esophagitis (27.2%). The rates of esophagitis are 2.5, 7, 9 and 13.4%, respectively, when the NTCP values are <10%, <15%, <20% and <25%. A significant association is found between esophagitis and dose/volume parameters V40 (P = 0.001) to V70 (P = 0.024).
New values of TD50, n and m offer a good description of the esophagitis distribution in our population. Compared to the use of this model with previously published parameters (associated with late toxicity) predictions of the model for acute esophagitis using the new parameters would indicate that, for a population of patients, the distribution of events as a function of uniform dose would occur with a lower mean uniform dose value (smaller TD50), over a wider range of uniform doses (larger m), while also exhibiting a bigger volume effect (larger n). These new parameter values are supported in essence by the correlations found for the dose/volume threshold parameters.
通过确定更新后的模型参数,然后将这些结果与其他剂量学参数的预测值进行比较,评估一种著名的正常组织并发症概率(NTCP)模型预测放射性食管炎的能力。
分析了101例接受外照射治疗的不可手术/不可切除的非小细胞肺癌患者的食管炎临床和剂量学数据。2级或更高等级的食管炎计为事件。使用最大似然分析确定Lyman正常组织并发症概率(NTCP)模型的参数(TD50、n和m),并与其他剂量/体积阈值进行比较,包括:接受>40 Gy(V40)至>75 Gy(V75)的食管百分比,以及食管最大剂量。
16例患者发生2-3级急性食管炎(无4级或5级)。最大似然分析得出新的Lyman模型参数为:TD50 = 51 Gy,n = 0.44,m = 0.32。无食管炎患者组的平均NTCP值(13.5%)显著低于有食管炎患者组(27.2%)(P < 0.001)。当NTCP值<10%、<15%、<20%和<25%时,食管炎发生率分别为2.5%、7%、9%和13.4%。发现食管炎与剂量/体积参数V40(P = 0.001)至V70(P = 0.024)之间存在显著关联。
TD50、n和m的新值很好地描述了我们研究人群中食管炎的分布情况。与使用先前公布的参数(与晚期毒性相关)的该模型相比,使用新参数的该模型对急性食管炎的预测表明,对于一组患者,作为均匀剂量函数的事件分布将在较低的平均均匀剂量值(较小的TD50)下,在更宽的均匀剂量范围内(较大的m)发生,同时也表现出更大的体积效应(较大的n)。这些新参数值在本质上得到了剂量/体积阈值参数相关性的支持。